Annual Working Capital
$593.47 M
-$269.95 M-31.26%
December 31, 2023
Summary
- As of February 12, 2025, BPMC annual working capital is $593.47 million, with the most recent change of -$269.95 million (-31.26%) on December 31, 2023.
- During the last 3 years, BPMC annual working capital has fallen by -$203.49 million (-25.53%).
- BPMC annual working capital is now -31.26% below its all-time high of $863.42 million, reached on December 31, 2022.
Performance
BPMC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$597.19 M
-$62.55 M-9.48%
September 30, 2024
Summary
- As of February 12, 2025, BPMC quarterly working capital is $597.19 million, with the most recent change of -$62.55 million (-9.48%) on September 30, 2024.
- Over the past year, BPMC quarterly working capital has dropped by -$13.60 million (-2.23%).
- BPMC quarterly working capital is now -43.24% below its all-time high of $1.05 billion, reached on September 30, 2022.
Performance
BPMC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BPMC Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.3% | -2.2% |
| 3 y3 years | -25.5% | -7.0% |
| 5 y5 years | +35.0% | -7.0% |
BPMC Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.3% | +46.8% | -43.2% | +47.7% |
| 5 y | 5-year | -31.3% | +46.8% | -43.2% | +47.7% |
| alltime | all time | -31.3% | >+9999.0% | -43.2% | +1490.4% |
Blueprint Medicines Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $597.19 M(-9.5%) |
| Jun 2024 | - | $659.74 M(+15.7%) |
| Mar 2024 | - | $570.00 M(-4.0%) |
| Dec 2023 | $593.47 M(-31.3%) | $593.47 M(-2.8%) |
| Sep 2023 | - | $610.79 M(-4.9%) |
| Jun 2023 | - | $642.31 M(-11.7%) |
| Mar 2023 | - | $727.66 M(-15.7%) |
| Dec 2022 | $863.42 M(+113.6%) | $863.42 M(-17.9%) |
| Sep 2022 | - | $1.05 B(+32.6%) |
| Jun 2022 | - | $793.42 M(+44.2%) |
| Mar 2022 | - | $550.22 M(+36.1%) |
| Dec 2021 | $404.26 M(-49.3%) | $404.26 M(-38.0%) |
| Sep 2021 | - | $652.16 M(+12.7%) |
| Jun 2021 | - | $578.67 M(-29.9%) |
| Mar 2021 | - | $825.27 M(+3.6%) |
| Dec 2020 | $796.96 M(+94.2%) | $796.96 M(+8.9%) |
| Sep 2020 | - | $731.55 M(+57.9%) |
| Jun 2020 | - | $463.23 M(-23.6%) |
| Mar 2020 | - | $606.39 M(+47.8%) |
| Dec 2019 | $410.30 M | $410.30 M(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $419.58 M(-21.0%) |
| Jun 2019 | - | $531.45 M(+46.9%) |
| Mar 2019 | - | $361.75 M(-17.7%) |
| Dec 2018 | $439.46 M(-31.6%) | $439.46 M(-13.7%) |
| Sep 2018 | - | $509.38 M(-10.9%) |
| Jun 2018 | - | $571.88 M(-0.7%) |
| Mar 2018 | - | $575.70 M(-10.4%) |
| Dec 2017 | $642.62 M(+234.8%) | $642.62 M(+76.2%) |
| Sep 2017 | - | $364.79 M(-8.4%) |
| Jun 2017 | - | $398.34 M(+111.7%) |
| Mar 2017 | - | $188.20 M(-1.9%) |
| Dec 2016 | $191.91 M(+26.4%) | $191.91 M(+42.1%) |
| Sep 2016 | - | $135.07 M(-10.2%) |
| Jun 2016 | - | $150.37 M(-13.5%) |
| Mar 2016 | - | $173.88 M(+14.6%) |
| Dec 2015 | $151.78 M(+265.6%) | $151.78 M(-10.3%) |
| Sep 2015 | - | $169.30 M(-9.5%) |
| Jun 2015 | - | $186.99 M(+398.0%) |
| Mar 2015 | - | $37.55 M(-9.5%) |
| Dec 2014 | $41.51 M(-5987.9%) | $41.51 M |
| Dec 2013 | -$705.00 K | - |
FAQ
- What is Blueprint Medicines annual working capital?
- What is the all time high annual working capital for Blueprint Medicines?
- What is Blueprint Medicines annual working capital year-on-year change?
- What is Blueprint Medicines quarterly working capital?
- What is the all time high quarterly working capital for Blueprint Medicines?
- What is Blueprint Medicines quarterly working capital year-on-year change?
What is Blueprint Medicines annual working capital?
The current annual working capital of BPMC is $593.47 M
What is the all time high annual working capital for Blueprint Medicines?
Blueprint Medicines all-time high annual working capital is $863.42 M
What is Blueprint Medicines annual working capital year-on-year change?
Over the past year, BPMC annual working capital has changed by -$269.95 M (-31.26%)
What is Blueprint Medicines quarterly working capital?
The current quarterly working capital of BPMC is $597.19 M
What is the all time high quarterly working capital for Blueprint Medicines?
Blueprint Medicines all-time high quarterly working capital is $1.05 B
What is Blueprint Medicines quarterly working capital year-on-year change?
Over the past year, BPMC quarterly working capital has changed by -$13.60 M (-2.23%)